Search research articles
Contact Us
Filters
Showing results (121-130 of 148) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer
Stefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Correction: ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Angel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Nature Communications
|
January 25, 2023
Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2018
ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Angel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G Stover, Heather A Parsons, Gavin Ha, et al.
Nature Communications
|
December 3, 2022
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Cell Reports
|
November 24, 2016
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Shawn F Johnson, Cristina Cruz, Ann Katrin Greifenberg, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
JCO Precision Oncology
|
July 7, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit
Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 148) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer
Stefania Morganti, Christopher J Gibson, Qingchun Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Correction: ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Angel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Nature Communications
|
January 25, 2023
Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2018
ER<sup>+</sup> Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Angel L Guerrero-Zotano, Thomas P Stricker, Luigi Formisano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G Stover, Heather A Parsons, Gavin Ha, et al.
Nature Communications
|
December 3, 2022
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Cell Reports
|
November 24, 2016
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Shawn F Johnson, Cristina Cruz, Ann Katrin Greifenberg, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
JCO Precision Oncology
|
July 7, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit
Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier, et al.
Page
of 15